Zydus Cadila And Bayer Extend Joint Venture By Three Years
As Bayer Zydus Pharma Continues To Operate In India
Executive Summary
Zydus Cadila and Bayer have announced the extension of their ten-year long joint venture by three more years. The companies will continue to focus on core therapies including cardiovascular diseases, diabetes, women’s health, ophthalmology and oncology, in India.